Journal ArticleDOI
Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
About:
This article is published in Yearbook of Gastroenterology.The article was published on 2010-01-01. It has received 584 citations till now. The article focuses on the topics: Hepatitis C virus.read more
Citations
More filters
Book ChapterDOI
Liver Transplantation for Hepatocellular Carcinoma (Hcc)
TL;DR: The complex decision making and management issues of patients with HCC, cirrhosis and possibly undergoing oncological therapies while waiting for an organ transplant poses challenges to the management team, not encountered in any other clinical or surgical field.
Journal ArticleDOI
Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection.
Maribel Rodriguez-Torres,Eric Lawitz,Bienvenido G. Yangco,Lennox J. Jeffers,Steven Han,Paul J. Thuluvath,Vinod K. Rustgi,Stephen A. Harrison,Reem Ghalib,John M. Vierling,Velimir A. Luketic,Philippe J. Zamor,Natarajan Ravendhran,Timothy R. Morgan,Brian L. Pearlman,Christopher B. O'Brien,Hicham Khallafi,Nikolaos Pyrsopoulos,George Kong,Fiona McPhee,Philip D. Yin,Eric Hughes,Michelle Treitel +22 more
TL;DR: The data support daclatasvir use in all-oral direct-acting antiviral combinations in treatment-naive black/African American, Latino, and white non-Latino patients with chronic HCV genotype 1 infection.
Journal ArticleDOI
Optimal M-Switch Surveillance Policies for Liver Cancer in Hepatitis C-Infected Population
TL;DR: A mixed-integer programming (MIP)-based framework is developed to systematically analyze a rich set of policies and determine the optimal HCC surveillance policies with the maximum societal net benefit and finds that a little flexibility in the policy structure as captured by M-switch policies is sufficient to capture almost as much benefit as complex fully dynamic policies.
References
More filters
Journal ArticleDOI
Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
TL;DR: Prevalence of hepatitis C cirrhosis and its complications will continue to increase through the next decade and will mostly affect those older than 60 years of age, but wider application of antiviral treatment and better responses with new agents could significantly reduce the impact of this disease in coming years.
Related Papers (5)
The Epidemiology of Chronic Hepatitis C and One-Time Hepatitis C Virus Testing of Persons Born During 1945 to 1965 in the United States
Co-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlates.
Fernando Herz Wolff,Fernando Herz Wolff,Sandra Cristina Pereira Costa Fuchs,Sandra Cristina Pereira Costa Fuchs,Nêmora Tregnago Barcellos,Nêmora Tregnago Barcellos,Paulo Ricardo de Alencastro,Maria Letícia Rodrigues Ikeda,Ajácio Bandeira de Mello Brandão,Ajácio Bandeira de Mello Brandão,Maicon Falavigna,Flávio Danni Fuchs +11 more
Human immunodeficiency virus/hepatits C virus coinfection in Spain: elimination Is feasible, but the burden of residual cirrhosis will be significant
Juan Berenguer,Inmaculada Jarrín,Leire Pérez-Latorre,Víctor Hontañón,María J. Vivancos,Jordi Navarro,María Jesús Téllez,Josep M. Guardiola,José Antonio Iribarren,Antonio Rivero-Juárez,Manuel Márquez,Arturo Artero,Luis Morano,Ignacio Santos,J. Moreno,M.C. Fariñas,María José Galindo,María Nieves Aja Hernando,Marta Montero,Carmen Cifuentes,Pere Domingo,José Sanz,Lourdes Domíngez,Oscar Ferrero,Belén de la Fuente,Carmen Rodríguez,Sergio Reus,José Hernández-Quero,Gabriel Gaspar,Laura Pérez-Martínez,Coral García,Lluís Force,S. Veloso,Juan Emilio Losa,Josep Vilaró,Enrique Bernal,Sari Arponen,Amat Ortí,Ángel Chocarro,Ramón Teira,Gerardo Alonso,Rafael Silvariño,Ana Vegas,Paloma Geijo,Josep Bisbe,Herminia Esteban,Juan González-García +46 more